Using Analytics to Maximize Copay Program Effectiveness


View web version

Using Analytics to Maximize Copay Program Effectiveness

With respect to patient access to care programs, manufacturers have been content to receive data on the numbers of redemptions, patients, and prescribers participating. As the copay industry has matured, these measures have become less and less adequate in supporting the brand team needs for robust ROI driving programs. Instead, pharmaceutical manufacturers are looking to analytics, with their rich sources of evidence, demonstrations of convincing payback, and sophisticated predictive models that include prescriber targeting, offer optimization, geographic analysis with big data. TrialCard provides an overview of the analytic data that we use to help our manufacturers to design the most effective campaigns and to assess their effectiveness.

Download More Information

For details on how to advertise in the MM&M Sponsored Promotion, please email Lawrence Nokes.

If you were sent this by a colleague and wish to subscribe to the MM&M Sponsored Promotion, please click here.

You are subscribed as:

To unsubscribe from the MM&M Sponsored Promotion click here.
To manage your entire MM&M profile login to your account.

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "". When configuring e-mail or spam
filter rules, please use this domain name.

Haymarket Media Inc
114 West 26th St 4th floor
New York, NY 10001

© 2014 Haymarket Media Inc.